EWTX position history
The shares of Edgewise Therapeutics (EWTX) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q1: 303,000 shares, $2.9M, 0.91% of portfolio, New
- 2022 Q2: 451,400 shares, $3.6M, 1.6% of portfolio, Add +49.0%
- 2022 Q3: 635,000 shares, $6.2M, 2.6% of portfolio, Add +40.7%
- 2022 Q4: 611,400 shares, $5.5M, 1.9% of portfolio, Reduce −3.7%
- 2023 Q1: 750,000 shares, $5M, 1.5% of portfolio, Add +22.7%
- 2023 Q2: 815,000 shares, $6.3M, 1.5% of portfolio, Add +8.7%
- 2023 Q3: 875,405 shares, $5M, 1.6% of portfolio, Add +7.4%
- 2023 Q4: 699,000 shares, $7.6M, 2.0% of portfolio, Reduce −20.2%
- 2024 Q1: 1,330,000 shares, $24M, 5.4% of portfolio, Add +90.3%
- 2024 Q2: 580,000 shares, $10M, 2.4% of portfolio, Reduce −56.4%
- 2024 Q3: 522,500 shares, $14M, 2.3% of portfolio, Reduce −9.9%
- 2024 Q4: 480,000 shares, $13M, 2.2% of portfolio, Reduce −8.1%
- 2025 Q1: 395,000 shares, $8.7M, 1.9% of portfolio, Reduce −17.7%
- 2025 Q2: 980,000 shares, $13M, 2.6% of portfolio, Add +148.1%
- 2025 Q3: 500,000 shares, $8.1M, 1.1% of portfolio, Reduce −49.0%
- 2025 Q4: 1,000,000 shares, $25M, 3.3% of portfolio, Add +100.0%
- 2026 Q1: 500,000 shares, $16M, 2.1% of portfolio, Reduce −50.0%
- 2026 Q2: 500,000 shares, $20M, 1.8% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|